External Comparison of Ibalizumab in Trials vs. Other Regimens in OPERA
Completed
Conditions studied: HIV-1-infection
In brief
Among heavily treatment experienced people living with HIV, the virologic effectiveness of ibalizumab + optimized background regimen from two clinical trials will be compared to non-ibalizumab-containing regimens in routine clinical care in the OPERA cohort.
Key facts
- Study ID
- NCT05495204
- Run by
- Epividian
- People needed
- 141
- Starts
- 2022-08-05
- Expected to finish
- 2023-02-20
- Last updated by the study team
- 2023-09-07
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Epividian — Durham, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.